ArticleFrontiers in genetics2025
Engineering novel features for diabetes complication prediction using synthetic electronic health records.
Article in Frontiers in genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Complication Risk Classification in Children and Adolescents With Type 1 Diabetes: Interpretable Machine Learning Study Based on Saudi Clinical Guidelines.JMIR formative research · 2026Article
- Federated multimodal AI for precision-equitable diabetes care.Frontiers in digital health · 2025Review
Corrections and comments
- Erratum issued
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes significantly affects millions of people worldwide, leading to substantial morbidity, disability, and mortality rates. Predicting diabetes-related complications from health records is crucial for early prevention and for the development of effective treatment plans. In order to predict four different complications of diabetes mellitus, i.e., retinopathy, chronic kidney disease, ischemic heart disease, and amputations, this study introduces a novel feature engineering approach. While developing the classification models, we utilize XGBoost feature selection method and various supervised machine learning algorithms, including Random Forest, XGBoost, LogitBoost, AdaBoost, and Decision Tree. These models were trained on synthetic electronic health records (EHR) generated by dual-adversarial autoencoders. These EHRs represent nearly 1 million synthetic patients derived from an authentic cohort of 979,308 individuals with diabetes. The variables considered in the models were the age range accompanied by chronic diseases that occur during patient visits starting from the onset of diabetes. Throughout the experiments, XGBoost and Random Forest demonstrated the best overall prediction performance. The final models, which are tailored to each complication and trained using our feature engineering approach, achieved an accuracy between 69% and 77% and an AUC between 77% and 84% using cross-validation, while the partitioned validation approach yielded an accuracy between 59% and 78% and an AUC between 66% and 85%. These findings imply that the performance of our method surpass the performance of the traditional Bag-of-Features approach, highlighting the effectiveness of our approach in enhancing model accuracy and robustness.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.